Systematic Assessment of Vascular Risk
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
It is hypothesized that patients with vascular disease are undertreated for modifiable risk factors, leading to increased morbidity and mortality in this population.
The objective of this study is to develop a comprehensive database that will demonstrate the current adequacy of risk factor management in this high risk population, and that will provide needed guidance for future treatment options.
| Condition |
|---|
|
Peripheral Vascular Disease |
| Study Type: | Observational |
| Study Design: | Observational Model: Defined Population Primary Purpose: Screening Time Perspective: Longitudinal Time Perspective: Retrospective/Prospective |
| Official Title: | Toronto Vascular Disease Risk Factor Assessment Program: Systematic Assessment of Vascular Risk |
Eligibility| Ages Eligible for Study: | 30 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
All patients who attend the Vascular Surgery Clinic at Toronto General Hospital, St. Michael’s Hospital, and St. Joseph’s Health Centre who have PAD, cerebrovascular disease (CBVD), or aneurysms will be eligible for this study. Patients who are currently enrolled in other clinical studies are eligible for this study; however proper adherence to the other study will take precedence over of the current proposal.
Contacts and Locations| Contact: Abby Skanda | 416 340 4800 ext 6285 | askanda@uhnresearch.ca |
| Canada, Ontario | |
| Toronto General Hospital | Recruiting |
| Toronto, Ontario, Canada, M5G 2C4 | |
| Principal Investigator: Thomas Lindsay, MD | |
| Principal Investigator: | Thomas Lindsay, M.D | Toronto General Hospital, University Health Network |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00378040 History of Changes |
| Other Study ID Numbers: | 01-541S |
| Study First Received: | September 15, 2006 |
| Last Updated: | September 15, 2006 |
| Health Authority: | Canada: Health Canada |
Additional relevant MeSH terms:
|
Vascular Diseases Peripheral Vascular Diseases Peripheral Arterial Disease Cardiovascular Diseases |
Atherosclerosis Arteriosclerosis Arterial Occlusive Diseases |
ClinicalTrials.gov processed this record on May 23, 2013